results of phase i/ii study of epcoritamab r-dhax/c in patients with r/r dlbcl eligible for autosct
Published 1 year ago • 107 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
1:38
phase ii study of epcoritamab in r/r lbcl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
1:46
phase ii study of acalabrutinib plus rice in r/r dlbcl
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
3:34
dose-escalation results from phase ib/iia trial of azd4573 acalabrutinib in r/r dlbcl
-
1:35
update on phase i study of plamotamab in r/r nhl
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
3:32
efficacy and tolerability results from a phase i/ii study of loxo-305 in b-cell malignancies
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
1:19
real-world outcomes of liso-cel therapy in r/r dlbcl
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma